Livalo and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported as a side effect among people who take Livalo (pitavastatin calcium), especially for people who are male, 60+ old, also take Pradaxa, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Bleeding disorders when taking Livalo. It is created by eHealthMe based on reports of 8,536 people who have side effects when taking Livalo from the FDA, and is updated regularly.

What is Livalo?

Livalo has active ingredients of pitavastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 8,802 Livalo users. Check the latest studies of Livalo.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,200 drugs and 1,648 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

On Jun, 10, 2026

8,536 people reported to have side effects when taking Livalo.
Among them, 11 people (0.13%) have Bleeding disorders.

Among these 11 people:

What is the gender of people who have Bleeding disorders when taking Livalo? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Bleeding disorders when taking Livalo? *

What are other drugs people take besides Livalo? *

What are other side effects people have besides Bleeding disorders? *

Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 2 people, 18.18%
Urine Output Decreased: 2 people, 18.18%
Urinary Tract Infection: 2 people, 18.18%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 18.18%
Biliary Tract Infection: 2 people, 18.18%
Renal Impairment (severely reduced kidney function): 2 people, 18.18%
Oedema Peripheral (superficial swelling): 2 people, 18.18%
Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 1 person, 9.09%
Anaemia (lack of blood): 1 person, 9.09%
Chronic Kidney Disease: 1 person, 9.09%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 63.64%
High Blood Pressure: 2 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 9.09%
Dizziness: 1 person, 9.09%
Age-Related Macular Degeneration: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Livalo and have Bleeding disorders?

- Check whether Bleeding disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Livalo:

Livalo (8,802 reports)

Browse all side effects of Livalo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding disorders:

Bleeding disorders (1,200 drugs)

Browse all the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,648 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pitavastatin calcium (the active ingredients of Livalo) and Livalo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.